期刊
JOURNAL OF FLUORINE CHEMISTRY
卷 128, 期 3, 页码 196-201出版社
ELSEVIER SCIENCE SA
DOI: 10.1016/j.jfluchem.2006.12.007
关键词
fluorine-18; [R-8,R-15,R-21; L-17]-VIP; [F-18]SFB; [F-18]SFMB; PET
Vasoactive intestinal peptide (VIP) receptors are expressed on various tumor cells in much higher density than somatostatin receptors, which provides the basis for radiolabeling VIP as tumor diagnostic agent. However, fast proteolytic degradation of VIP in vivo limits its clinical application. With the aim to develop and evaluate new ligands for depicting the VIP receptors with positron emission tomography (PET), the structure modified [R-8,R-15.21, L-17]-VIP analog was radiolabeled with F-18 using two different methods. With the first method, N-4-[F-18]fluorobenzoyl-[R-8,R-15.21, L-17]-VIP ([F-18]FB-[R-8,R-15.21, L-17]-VIP 7) was produced in a decay-coffected radiochemical yield (RCY) of 33.6 +/- 3%, a specific radioactivity of 255 GBq/mu mol (n = 5) within 100 min in four steps. Similarly, N-4-[F-18](fluoromethyl)-benzoyl-[R-8,R-15.21, L-17]-VIP ([F-18]FMB-[R-8,R-15.21, L-17]-VIP 8) was synthesized in a RCY of 34.85 +/- 5%, a specific radioactivity of 180 GBq/mu mol (n = 5) within 60 min in only one step. The two products 7 and 8 were both shown good stability in HSA. Moreover, the low bone uptakes of 7 and 8 in vivo of mice showed good defluorination stability. (c) 2006 Elsevier B.V. All rights reserved.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据